Venus Concept (NASDAQ:VERO) Trading 5.5% Higher – Should You Buy?

Venus Concept Inc. (NASDAQ:VEROGet Free Report)’s share price shot up 5.5% on Tuesday . The company traded as high as $2.34 and last traded at $2.32. 40,180 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 383,480 shares. The stock had previously closed at $2.20.

Venus Concept Stock Performance

The company has a market cap of $3.30 million, a price-to-earnings ratio of -0.29 and a beta of -0.03. The company has a current ratio of 1.86, a quick ratio of 1.18 and a debt-to-equity ratio of 2.83. The stock’s fifty day simple moving average is $3.02 and its 200 day simple moving average is $3.51.

Venus Concept (NASDAQ:VEROGet Free Report) last posted its quarterly earnings results on Thursday, May 15th. The company reported ($17.44) EPS for the quarter, missing the consensus estimate of ($14.08) by ($3.36). The business had revenue of $13.64 million for the quarter, compared to analyst estimates of $14.59 million.

About Venus Concept

(Get Free Report)

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.

Further Reading

Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.